https://www.linkedin.com/in/minhong-jang-a031b229/?originalSubdomain=kr

ë°±ìŠ¹ìš± ì˜ì¥ë‹˜
mission: conquer cancer through ai
- cancer diagnosis support solutions (insight), cancer treatment support solution (scope) ì§„ë‹¨ê³¼ ì¹˜ë£Œë¡œ ìƒì¡´ë¥ ì„ ë†’ì¸ë‹¤

- ë©´ì—­í•­ì•”ì œì˜ (immune cell distribution immunca)

ìœ„ëŒ€í•œ íšŒì‚¬ëŠ” ì•„ë‹ˆë‹¤ (ì•ì„  ì—°ì‚¬ì™€ ì—°ê´€)

â­ï¸right team, right direction
## team
6 engineer in kaist - who do we want? caegory (lunit's core culture)
a team of smart team players, united by a passion for growth and a global mindset to tackle big, meaningful challenges
- learning unit = lunit

domain expertise is something that can be learned or built over time - esp. in early stage

however, we were missing a piece in globalize 
- medical research
- clinical env understang
- global business dev
-> hire brandon suh (), 2019 ëŒ€í‘œë¡œ ì„œë²”ì„
![[Pasted image 20250405202954.png|100]]

Q1: what's next breakthrough tech that'll change the world
- image -> 2012 imagenet (supervision; jeffrey hinton, acquired by google), 
- dnn
Q2: what's biggest problem?
- dress recognition, description, shopping (similar result) - user test
- technology keeps growing, where's the market impact 
our product should solve important problem bettern than human, we should have upside potential, field where we have confidence to excel
-> medicine (not fashion)
art of medicine, evidence based medicine, data-driven medicine

pain point: mammograph 30% is missed (), ì¡°ì§ê²€ì‚¬ëŠ” 4ëª… ì¤‘ 1ëª… ì˜ê²¬ ë‹¤ë¦„

how to build a great company -> ğŸ˜‚not great company

Q. ì •ì¹˜, recipe of collab - not equal equity, similar salary, ê²°êµ­ lunitì˜ë˜ê¸° ìœ„í•´ ì‹¸ìš°ëŠ”ê±°ë‹¤, ìŠ¹ìš±ì„ ë¯¸ì›Œí•˜ê¸´í–ˆì§€ë§Œ ì‹«ì–´í•˜ì§„ ì•Šì•˜ë‹¤ (ê°œì¸ ì´ìµ ì·¨í•œì ì€ ì—†ì—ˆë‹¤)

ì¹œêµ¬ì™€ ì°½ì—… / ê°œì¸ì‚¬, ì˜¤ë«ë™ì•ˆ. ë¹„ì¦ˆë‹ˆìŠ¤í•˜ë‹¤ê°€ ê¹¨ì ¸ë„ 
ìƒˆë¡œìš´ ê¸°ìˆ ë¡œ ë¬¼ê±´ (ì›ë˜í•˜ë˜ê±¸ ë” ì˜í•˜ë“ , ì‹¸ê²Œ ), 

data acquisition, sales (subscriptionë°©ì‹)

pricing -> ì˜ì‚¬ì˜ 2,30% (readingí• ë•Œë§ˆë‹¤ fee)ê°€ upper limit
- two market ì§ì ‘ ì˜ì‚¬ (50%)  vs medical device company (50%)
- out of pocket , ì •ë¶€ í—ˆê°€ ë…¸ë ¥í•¨ (í˜„ì¬ëŠ” ë¹„ê¸‰ì—¬ë¡œ), ì¼ë³¸ê³¼ ê°™ì´í•¨
- ìµœì‹ ë™í–¥ - path ai (boston - europen; clinical trila data analysis ìŠ¹ì¸ë‚¨), ai + therapeutic 
